General
Preferred name
PRAMIRACETAM
Synonyms
CI-879 ()
CI-879 (free base) ()
CI-879,Pramistar ()
Amacetam hydrochloride ()
Pramiracetam hcl ()
Pramiracetam hydrochloride ()
CI-879 [SULFATE] ()
Amacetam sulfate ()
Amacetam sulphate ()
Pramiracetam sulphate ()
PRAMIRACETAM SULFATE ()
P&D ID
PD010924
CAS
68497-62-1
75733-50-5
72869-16-0
Tags
available
drug candidate
drug
Drug indication
Brain disease
Cognition Adjuvant
Drug Status
approved
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Pramiracetam is a central nervous system stimulant and nootropic agent belonging to the racetam family of drugs. It is a more potent nootropic drug derived from piracetam.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
15
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMatrix
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
45
Molecular Weight
269.21
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
7
Ring Count
1
Aromatic Ring Count
0
cLogP
0.84
TPSA
52.65
Fraction CSP3
0.86
Chiral centers
0.0
Largest ring
5.0
QED
0.75
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Indication
senile dementia
MOA
acetylcholine receptor agonist
Pathway
Metabolic Enzyme/Protease
Target
Prolyl Endopeptidase (PREP)
Source data
